Vonaprument
Sponsors
Annexon, Inc.
Conditions
Geographic Atrophy
Phase 3
A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprument (Formerly ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA)
Active, not recruitingNCT06510816
Start: 2024-07-30End: 2027-07-31Updated: 2026-05-04
An Open-label Extension Study of the Long-Term Safety of Vonaprument (ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA)
Not yet recruitingNCT07807969
Start: 2026-09-30End: 2029-07-31Target: 605Updated: 2026-09-08